Nine-month angiographic and two-year clinical follow-up of novel biodegradable-polymer arsenic trioxide-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease.

@article{Shen2015NinemonthAA,
  title={Nine-month angiographic and two-year clinical follow-up of novel biodegradable-polymer arsenic trioxide-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease.},
  author={Li Shen and Wei Yang and Jia-Sheng Yin and Xuebo Liu and Yi-zhe Wu and Ai Sun and Juying Qian and Junbo Ge},
  journal={Chinese medical journal},
  year={2015},
  volume={128 6},
  pages={768-73}
}
BACKGROUND Despite great reduction of in-stent restenosis, first-generation drug-eluting stents (DESs) have increased the risk of late stent thrombosis due to delayed endothelialization. Arsenic trioxide, a natural substance that could inhibit cell proliferation and induce cell apoptosis, seems to be a promising surrogate of sirolimus to improve DES performance. This randomized controlled trial was to evaluate the efficacy and safety of a novel arsenic trioxide-eluting stent (AES), compared… CONTINUE READING
2 Citations
20 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Similar Papers

Loading similar papers…